C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 413/06 (2006.01) A61K 31/445 (2006.01) A61K 31/454 (2006.01) C07D 211/26 (2006.01) C07D 211/62 (2006.01)
Patent
CA 2439119
Certain novel 4-substituted N-acylated piperidine derivatives are agonists of the human melanocortin receptor(s) and, in particular, are selective agonists of the human melanocortin-4 receptor (MC-4R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the activation of MC-4R, such as obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction.
Certains nouveaux dérivés N-acylés de la pipéridine substitués en 4 sont des agonistes du récepteur de la mélacortine humaine, et en particulier des agonistes sélectifs du récepteur 4 de la mélacortine humaine (MC-4R). Ils s'avèrent utiles pour le traitement, le contrôle ou la prévention de maladies ou de troubles dus à l'activation de la MC-4R, tels que l'obésité, le diabète, les dysfonctions sexuelles de l'homme dont celles de l'érection, et les dysfonctions sexuelles de la femme.
Goulet Mark T.
Nargund Ravi P.
Ujjainwalla Feroze
Walsh Thomas F.
Warner Daniel
Merck & Co. Inc.
Merck Sharp & Dohme Corp.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Acylated piperidine derivatives as melanocortin-4 receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acylated piperidine derivatives as melanocortin-4 receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acylated piperidine derivatives as melanocortin-4 receptor... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1361250